Workflow
医工融合
icon
Search documents
科学与健康丨AI赋能!2025年服贸会数智医疗有温度
Xin Hua Wang· 2025-09-13 12:21
Core Insights - The 2025 Service Trade Fair showcased innovative healthcare solutions, including AI-assisted self-diagnosis rooms and wearable devices for real-time health monitoring, highlighting the integration of technology in healthcare [2][5]. Group 1: AI and Technology in Healthcare - AI self-diagnosis rooms and facial expression analysis systems were featured, demonstrating advancements in digital healthcare [2]. - The "AI consultation" platform from the China Academy of Chinese Medical Sciences offers a comprehensive self-service experience, enhancing patient interaction with healthcare services [3]. - A new generation of surgical robots, including a microwave water knife and AI catheter shaping robots, was introduced, addressing common challenges in minimally invasive surgeries [6][8]. Group 2: Traditional Chinese Medicine and Innovation - The integration of traditional Chinese medicine with technology was evident, with devices like a small-scale meridian conditioning robot for treating tension-type headaches [3]. - The "Gongyi·Qizhi" large model project aims to create a smart brain for traditional Chinese medicine, enhancing the efficiency of healthcare delivery [3][5]. Group 3: Pediatric Health Solutions - The fair highlighted intelligent solutions for children's health, including AI-powered eye screening devices that assist local doctors in providing quality care [9]. - A companion robot designed for children with high-functioning autism offers interactive assessments and training, supporting early diagnosis and rehabilitation [11].
“AI+医疗”需要数据投喂,你愿意共享你的病历数据吗?
Nan Fang Du Shi Bao· 2025-09-11 13:22
Group 1 - The core theme of the BOE IPC·2025 summit is "Integration of Medicine and Engineering for a Smart Future," focusing on the innovative ecosystem of health and medical engineering [1] - BOE is transitioning from a display screen company to the "AI + Medical" field, actively promoting the construction of a digital hospital system and aiming to create a "digital and visual BOE hospital" [3] - BOE has established a health big data platform managing nearly 5 billion data entries, providing comprehensive health services to over 5 million customers through five digital hospitals and one integrated medical community [3] Group 2 - The development of "AI + Medical" requires vast amounts of high-quality data, with current challenges including data silos and inconsistent standards across medical institutions, hindering effective data utilization and sharing [4] - Privacy concerns and unclear data ownership further complicate the sharing of medical data, creating significant barriers to collaboration [4] - There is a low utilization rate of vast amounts of medical data, and the lack of effective quantitative models to extract data value prevents the realization of its potential [5]
BOE IPC·2025京东方智慧医工论坛在京举办
Huan Qiu Wang· 2025-09-11 10:44
Group 1 - The core theme of the BOE IPC·2025 summit is "Integration of Medicine and Engineering, Intelligent Innovation for the Future," focusing on the innovative ecosystem of health and medical integration [1] - BOE's Senior Vice President Zhang Tao emphasized that technological advancements are driving improvements in healthcare, marking the entry of the health industry into the 4.0 intelligent era, where AI and medical integration are transforming traditional treatment models [2][3] - The company is actively building a digital hospital system, aiming to create a "digital and visible BOE hospital," with a health big data platform managing nearly 5 billion data entries [3] Group 2 - BOE operates five digital hospitals and one integrated medical and nursing community, providing comprehensive health services to over 5 million customers, covering prevention, diagnosis, and rehabilitation [3] - The company is focusing on end-to-end innovation in health technology, with over 30 collaborative projects and more than 1,000 authorized patents, addressing industry pain points and contributing to the development of national and international standards [3] - The technology innovation exhibition showcased advanced medical technologies, including myopia prevention and smart diagnosis, highlighting BOE's commitment to enhancing healthcare service quality and accessibility through AI [4][5]
广东探路医工深度融合,加速前沿技术从“实验室”走向“病房”
Group 1 - The core viewpoint emphasizes the importance of technology transfer in driving high-quality development in the healthcare industry, highlighting the collaboration between research institutions and pharmaceutical companies as a key factor in medical innovation [1][2][3] - The "Hundred Enterprises and Hundred Hospitals Guangdong Medical Tour" event aims to facilitate the integration of medical and engineering sectors, ensuring precise alignment between clinical needs and research efforts, thereby accelerating the commercialization of scientific achievements [2][8] - The first batch of 133 biomedicine technology transfer achievements was released, showcasing the need for improved conversion rates in the biomedicine sector, which currently faces challenges such as insufficient innovation and immature supply chains [3][4] Group 2 - Guangdong province leads the nation in the number of pharmaceutical and medical device production enterprises, with a total of 8,983 companies and over 1.76 million registered products as of June 2023 [4] - The biomedicine industry in Dongguan has matured over the past decade, with over 500 biopharmaceutical companies established, including notable leaders in various sub-sectors [9][10] - Dongguan's "Songhu Pharmaceutical Port" is positioned as a central hub for biopharmaceutical innovation, aiming to create a comprehensive ecosystem for research, incubation, and industrialization [10][11]
广东探路医工深度融合 加速前沿技术从“实验室”走向“病房”
Core Insights - The emergence of Angladevi highlights the effective collaboration between clinical needs and basic research, showcasing a successful model of medical innovation through deep integration of medicine and modern engineering technology [1][3] - Guangdong province is leveraging the "Hundred Enterprises and Hundred Hospitals" initiative to enhance the integration of medical and industrial sectors, aiming to accelerate the transformation of scientific research achievements into practical applications [2][6] Industry Developments - The first batch of 133 key biopharmaceutical technology transformation achievements was released, including projects from various medical institutions and universities, aimed at fostering collaboration between academia and industry [3][6] - Guangdong's biopharmaceutical industry is experiencing significant growth, with the province leading the nation in the number of pharmaceutical and medical device production enterprises, as well as in the approval of innovative products [4][3] Challenges and Opportunities - The biopharmaceutical sector faces challenges such as low transformation rates of scientific achievements and the need for a more mature supply chain and manufacturing system [3][4] - The establishment of the Songhu Pharmaceutical Port as a specialized industrial park aims to create a comprehensive ecosystem for biopharmaceutical research and development, addressing the complexities and specialization of the industry [8][7] Future Directions - Guangdong plans to enhance its biopharmaceutical technology transformation system and incentives, further promoting the application of scientific achievements and the integration of production and sales [6][9] - The focus on building high-level medical institutions' support in drug and device development is expected to create more integrated medical and industrial scenarios, contributing to the establishment of Dongguan as a new hub for the biopharmaceutical industry [9][7]
决胜“十四五” 打好收官战丨我国医疗装备实现新突围
Sou Hu Cai Jing· 2025-08-27 13:53
Core Viewpoint - The Chinese medical equipment industry has achieved significant growth during the "14th Five-Year Plan" period, with a focus on high-end and intelligent medical devices, marking a shift from reliance on imports to domestic innovation and production [1][3][10]. Market Growth - The annual compound growth rate of China's medical equipment industry is approximately 10.7% during the "14th Five-Year Plan," with the market size expected to reach 1.35 trillion yuan by 2024, making it the second-largest market globally [2][3]. - By the end of 2024, the number of medical device manufacturing companies in China is projected to exceed 33,000, representing a 27.8% increase compared to the end of the "13th Five-Year Plan" [2][3]. Technological Advancements - The industry is witnessing a trend towards high-end and intelligent medical equipment, with innovations such as advanced imaging devices and integrated radiation therapy technologies being introduced [4]. - Since the beginning of the "14th Five-Year Plan," 315 innovative medical devices have been approved, with 272 of them being domestic products, accounting for 86.3% [4]. Global Integration - Chinese medical equipment is increasingly being integrated into global markets, with companies like MicroPort and Mindray exporting products to over 40 countries and regions, achieving significant overseas revenue [4]. - The industry is transitioning from isolated breakthroughs to systematic integration, enhancing global collaboration and resource sharing [4][9]. Policy Support - The Chinese government has implemented multiple policies to promote high-quality development in the medical equipment sector, focusing on research, industry, and application [7][8]. - Initiatives include the establishment of green channels for innovative medical devices and ongoing projects to improve medical equipment conditions in grassroots healthcare [8]. Patient Benefits - The advancements in domestic medical equipment have led to improved healthcare accessibility, allowing patients to receive high-quality medical services closer to home [9][10]. - Technologies such as AI-assisted diagnostics and remote surgery systems are breaking geographical barriers, enabling better healthcare resource distribution [9].
助力首都未来产业发展 中国药谷特色产业园再落一子
转自:新华财经 在中国药谷的核心版图上,一座以"医工融合"为引擎的创新园区正崭露头角——中关村(大兴)生物医用材料产业园正以独特的定位和完善的服务,吸引着 众多生物医药前沿企业和人才在此汇聚,书写着医疗健康与前沿科技跨界融合的新篇章。 黄金区位 科学布局 中关村(大兴)生物医用材料产业园位于中关村大兴生物医药产业基地核心区域,是聚焦医工融合创新的专业化产业载体。园区坐落于基地高端产业园最密 集的核心地带,周边医疗器械园、华润产业园等产业载体星罗棋布,形成强大的产业集群效应。交通网络更是堪称"四通八达":距六环路北臧村出口仅1.5 公里,北京地铁四号线生物医药基地站4公里可达,毗邻北京大兴国际机场,大广、京港澳等多条高速环绕,让"半小时进京、1小时通达津冀、4小时连接全 国"成为现实。 园区在空间建设上独具匠心,重点打造了专业孵化、科技服务、配套服务三大核心功能,满足企业在不同发展阶段的需求。10.7万平方米的总建筑面积里, 7栋建筑通过连廊巧妙相连,既保持独立功能又实现高效联动,为企业打造出"产学研用"无缝衔接的物理空间。A栋承担着医药基地政务中心和园区展示区 的重要角色,是外界了解园区的窗口;B、C、D、E ...
大湾区国创中心国际总部入驻河套科创中心
Shen Zhen Shang Bao· 2025-08-11 23:25
Group 1 - The Guangdong-Hong Kong-Macao Greater Bay Area National Technology Innovation Center International Headquarters has officially settled in the He Tao Science and Technology Innovation Center, aiming to leverage institutional advantages to integrate innovation resources efficiently [1] - The center is a national-level comprehensive results transformation platform jointly deployed by Guangdong Province, Shenzhen City, and Tsinghua University, focusing on key areas such as biomedicine, high-performance materials, and artificial intelligence [1] - The headquarters has been awarded the "Shenzhen Medical-Engineering Integration Results Transformation Demonstration Base" and signed strategic cooperation agreements with the Guangdong Provincial Small Molecule New Drug Innovation Center and Ruizhi Pharmaceutical Technology Co., Ltd. to create a deep integration service system for medical engineering [1] Group 2 - The two-year anniversary of the State Council's "He Tao Shenzhen Park Development Plan" highlights the development positioning of the "pilot transformation cluster area" within the Greater Bay Area [2] - Over the past two years, the He Tao Shenzhen Park has established ten industry-level pilot platforms, including those for new optical materials and automated drug discovery, accelerating the integration of technological and industrial innovation [2] - The planning aims to assist in the realization of cutting-edge innovative results into practical applications [2]
大湾区国创中心国际总部入驻河套科创中心 现场发布首批7个前沿科技项目
Shen Zhen Shang Bao· 2025-08-11 22:44
Group 1 - The Guangdong-Hong Kong-Macao Greater Bay Area National Technology Innovation Center International Headquarters has officially settled in the He Tao Science and Technology Innovation Center, aiming to leverage institutional advantages to integrate innovation resources efficiently [1] - The center is a national-level comprehensive results transformation platform jointly deployed by Guangdong Province, Shenzhen City, and Tsinghua University, focusing on key areas such as biomedicine, high-performance materials, and artificial intelligence [1] - The headquarters has been awarded the titles of "Shenzhen Medical-Engineering Integration Results Transformation Demonstration Base" and "Shenzhen Medical Security Bureau Industry Innovation Empowerment Window," and has signed strategic cooperation agreements with local innovation centers and companies [1] Group 2 - The two-year anniversary of the State Council's "He Tao Shenzhen Park Development Plan" highlights the development positioning of the "Greater Bay Area Pilot Transformation Cluster" and the task of building an internationally competitive industrial pilot transformation base [2] - Over the past two years, the He Tao Shenzhen Park has established ten industry-level pilot platforms, including those for new optical materials and automated drug discovery, accelerating the integration of technological and industrial innovation [2]
汇聚顶尖智慧,加速医工融合技术转化!深圳成立两大关键平台
Nan Fang Du Shi Bao· 2025-08-11 15:22
Group 1 - The forum "Digital Intelligence as a Bridge: Medical Engineering Integration" was held in Shenzhen, marking a significant step in Shenzhen's health technology innovation and the transition from "passive medical care" to "active health" strategy [1][3] - The event was organized by the Shenzhen Hospital Association and included the establishment of the "Medical Engineering Integration Active Health Research Institute" and the "CHART Alliance" in the Guangdong-Hong Kong-Macao Greater Bay Area, which are key strategic outcomes of the forum [1][2] - The Medical Engineering Integration Active Health Research Institute aims to create a comprehensive active health technology engine and lead the formulation of national and industry standards to shift the medical model towards a "people-centered health" approach [1][2] Group 2 - The CHART Alliance focuses on comprehensive management of vascular diseases and aims to build a full-service system from prevention to rehabilitation, accelerating the application and innovation of cardiovascular imaging and AI technology in the Greater Bay Area [2] - The establishment of these platforms is a practical response to national health initiatives, gathering top expertise to drive the transition from "passive medical care" to "active health" and injecting innovation into the health sector [2] - The forum featured three thematic roundtable discussions involving 16 leading experts, addressing key topics such as AI imaging diagnosis, interdisciplinary talent cultivation, and the application of new cardiovascular imaging technologies [2][3] Group 3 - The successful hosting of the forum through innovative mechanisms and strategic layouts has established a high-end ecosystem for medical engineering integration, providing a replicable practice model for the "Healthy China 2030" and "Digital Shenzhen" strategies [3] - This event signifies a new phase of scaled, standardized, and systematic development in Shenzhen's medical engineering integration efforts, laying a solid foundation for creating a global health innovation hub in the Greater Bay Area [3]